Log In
Print this Print this

GDC-0084, RG7666

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionPhosphoinositide 3-kinase (PI3K) inhibitor
Molecular Target Phosphoinositide 3-kinase (PI3K)
Mechanism of ActionPhosphoinositide 3-kinase (PI3K) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationBrain cancer
Indication DetailsTreat progressive or recurrent high-grade glioma
Regulatory Designation
PartnerGenentech Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today